The Pharmaceutical Research and Manufacturers of America (PhRMA) appreciates the opportunity to submit comments in connection with the Patent and Trademark Office’s (PTO or Office) Request for Comments on a Proposed Pilot Program Exploring an Alternative Approach to Institution Decisions in Post Grant Administrative Reviews.
PhRMA’s member companies are leading research-based pharmaceutical innovators devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA’s membership ranges in size from small emerging companies to multi-national corporations that employ tens of thousands of Americans, and encompasses both research-based pharmaceutical and biotechnology companies. The U.S. biopharmaceutical sector supports a total of 3.4 million jobs throughout the economy, and directly employs more than 810,000 Americans. The industry’s overall economic impact is substantial, accounting for nearly $800 billion in economic output.Download